Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE) [NA]

View source ↗

Summary

A clinical trial evaluating human albumin infusion for patients with liver cirrhosis and overt hepatic encephalopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Albumin Infusion (Human serum albumin)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Overt Hepatic Encephalopathy | NA | Status: RECRUITING